Semi-Annual Statement Of Income

Fuso Pharmaceutical Industries,Ltd. - Filing #7732502

Concept 2017-04-01 to
2017-09-30
2016-04-01 to
2016-09-30
Semi-annual statement of income
Statement of income
Net sales
23,066,000,000 JPY
23,718,000,000 JPY
Cost of sales
16,423,000,000 JPY
17,022,000,000 JPY
Gross profit (loss)
6,642,000,000 JPY
6,696,000,000 JPY
Ordinary profit (loss)
403,000,000 JPY
514,000,000 JPY
Selling, general and administrative expenses
6,315,000,000 JPY
6,261,000,000 JPY
Extraordinary losses
3,000,000 JPY
17,000,000 JPY
Selling, general and administrative expenses
Salaries
1,247,000,000 JPY
1,263,000,000 JPY
Depreciation
218,000,000 JPY
186,000,000 JPY
Operating profit (loss)
326,000,000 JPY
435,000,000 JPY
Profit (loss) before income taxes
399,000,000 JPY
497,000,000 JPY
Income taxes - current
79,000,000 JPY
379,000,000 JPY
Non-operating income
262,000,000 JPY
270,000,000 JPY
Income taxes - deferred
54,000,000 JPY
-288,000,000 JPY
Non-operating income
Interest income
10,000,000 JPY
10,000,000 JPY
Dividend income
39,000,000 JPY
38,000,000 JPY
Income taxes
133,000,000 JPY
90,000,000 JPY
Non-operating expenses
186,000,000 JPY
190,000,000 JPY
Non-operating expenses
Interest expenses
108,000,000 JPY
111,000,000 JPY
Profit (loss)
265,000,000 JPY
406,000,000 JPY
Extraordinary losses
Loss on sale of non-current assets
JPY
5,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.